# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-027755
Filing Date
2021-11-10
Accepted
2021-11-10 08:00:37
Documents
55
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1034324
2 |  | ex10-1.htm | EX-10.1 | 92133
3 |  | ex31-1.htm | EX-31.1 | 18301
4 |  | ex31-2.htm | EX-31.2 | 18320
5 |  | ex32-1.htm | EX-32.1 | 6385
6 |  | ex32-2.htm | EX-32.2 | 6415
7 |  | ex10-1_001.jpg | GRAPHIC | 2439
| Complete submission text file | 0001493152-21-027755.txt |  | 5439957

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL SCHEMA FILE | lixt-20210930.xsd | EX-101.SCH | 45541
9 | XBRL CALCULATION FILE | lixt-20210930_cal.xml | EX-101.CAL | 33379
10 | XBRL DEFINITION FILE | lixt-20210930_def.xml | EX-101.DEF | 230480
11 | XBRL LABEL FILE | lixt-20210930_lab.xml | EX-101.LAB | 366614
12 | XBRL PRESENTATION FILE | lixt-20210930_pre.xml | EX-101.PRE | 281798
13 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 807002

Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39717 | Film No.: 211394476
SIC: 2834 Pharmaceutical Preparations